Since its inception nearly three years ago, IPG Health has invested in integrating systems, processes and people across its global network. This was accelerated by key leadership appointments focused on integrating the use of data and tech-enabled platforms across every aspect of its business. “The imperative for health and pharma marketers remains clear – harness this transformative potential to reshape HCP and consumer engagement, drive behavioral change, while accelerating brand value, *with* speed and scale,” said Dana Maiman, CEO of IPG Health. “Interconnectivity and interoperability have been fundamental to the success of IPG Health and enable us to keep pace with tech evolution. It’s how we’ve successfully combined creativity with deep science, data, technology and intelligence – both human and artificial – to keep our clients and their brands at the forefront of innovation.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IPG:
- Interpublic Group price target lowered to $31 from $32 at Wells Fargo
- Interpublic Group price target raised to $33 from $32 at Macquarie
- Interpublic Group reports Q1 adjusted EPS 36c, consensus 35c
- IPG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- IPG’s Commonwealth//McCann Recognized as GM Supplier of Year